HoldingsChannel.com
| Date | Insider | Price | Amount |
|---|---|---|---|
| 2-27-2024 Insider Buy |
Daniel D. Burton Chief Executive Officer |
$7.81 CAGR » |
$204,525.06 26,200 shares |
| 5-12-2023 Insider Buy |
Daniel D. Burton Chief Executive Officer |
$10.19 CAGR » |
$499,593.87 49,050 shares |
| 11-11-2022 Insider Buy |
Daniel D. Burton Chief Executive Officer |
$10.14 CAGR » |
$1,998,213.26 197,078 shares |
| 9-8-2022 Insider Buy |
Daniel D. Burton Chief Executive Officer |
$10.99 CAGR » |
$996,970.43 90,750 shares |
| 8-19-2022 Insider Buy |
Duncan Gallagher |
$11.66 CAGR » |
$174,946.74 15,000 shares |
| 8-9-2022 Insider Buy |
Daniel D. Burton Chief Executive Officer |
$11.62 CAGR » |
$2,051,397.47 176,522 shares |
Also See: Institutional Holders of HCAT
Also See: SEC filings
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 02/28/2024 | |
| End date: | 05/03/2024 | |
| Start price/share: | $8.16 | |
| End price/share: | $6.48 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -20.59% | |
| Annualized Gain: | -117.42% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $7,941.00 | |
| Years: | 0.18 | |
HCAT Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent HCAT insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding HCAT
 Free HCAT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
|
|
|
Other companies seeing insider buying close in time to when the HCAT Insider Buying occurred are:
ARQT Insider Buying
|
